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Long‑term effectiveness 
of a lifestyle intervention 
on the prevention of type 2 
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country
Mojtaba Lotfaliany1,2, Mohamad Ali Mansournia3, Fereidoun Azizi4, Farzad Hadaegh 2, 
neda Zafari2, Arash Ghanbarian2, Parvin Mirmiran5, Brian Oldenburg 1 & Davood Khalili2*
This study aims to assess the effects of a community‑based lifestyle intervention program on the 
incidence of type 2 diabetes (T2D). For this purpose, three communities in Tehran were chosen; 
one community received a face‑to‑face educational session embedded in a long‑term community‑
wide lifestyle intervention aimed at supporting lifestyle changes. We followed up 9,204 participants 
(control: 5,739, intervention: 3,465) triennially from 1999 to 2015 (Waves 1–5). After a median 
follow‑up of 3.5 years (wave 2), the risk of T2D was 30% lower in the intervention community as 
compared with two control communities by (Hazard‑ratio: 0.70 [95% CI 0.53; 0.91]); however, 
the difference was not statistically significant in the following waves. After a median follow‑up 
of 11.9 years (wave 5), there was a non‑significant 6% reduction in the incidence of T2D in the 
intervention group as compared to the control group (Hazard‑ratio: 0.94 [0.81, 1.08]). Moreover, 
after 11.9 years of follow‑up, the intervention significantly improved the diet quality measured by 
the Dietary Approaches to Stop Hypertension concordance (DASH) score. Mean difference in DASH 
score in the intervention group versus control group was 0.2 [95% CI 0.1; 0.3]. In conclusion, the 
intervention prevented T2D by 30% in the short‑term (3.5 years) but not long‑term; however, effects 
on improvement of the diet maintained in the long‑term.
Registration: This study is registered at IRCT, a WHO primary registry (https ://irct.ir). The registration 
date 39 is 2008‑10‑29 and the IRCT registration number is IRCT138705301058N1.
The burden of type 2 diabetes (T2D) is high and increasing in Low- and Middle-Income Countries (LMICs) 
like  Iran1. Iranians have a high risk of developing T2D with an incidence rate of the disease being 11 per 1,000 
person-years2. Given the high burden of T2D in Iran, there is an urgent need for effective prevention programs 
for T2D that can be implemented nationally.
Community-wide strategies are vital to have a major impact on trends in raising the T2D  epidemic3–5. Sev-
eral studies have assessed the effects of community-wide lifestyle interventions on the prevention of T2D. For 
this aim, community-wide interventions were delivered to a community living within a certain geographic area 
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and their outcomes were compared with other similar communities in distinct geographic  areas6–8. Previous 
community-wide lifestyle intervention studies showed a reduction in risk factors of T2D including significant 
beneficial effects on poor diet  habits9–13,  obesity9,14–17, low physical  activity9,13,18, and  smoking9–13,16,19–28. However, 
only a few of them assessed the effect of their program on the incidence of  T2D14,29. Moreover, none of the previ-
ous studies evaluated the maintenance of the effects of community-wide lifestyle interventions after a decade. 
Most community-wide lifestyle intervention studies have been conducted in high-income countries and there 
are only a few studies from  LMICs6–8. Therefore, there is a pressing need for robust evidence on the long-term 
effects of community-wide lifestyle interventions on the incidence of T2D and related risk factors, especially in 
LMICs where the burden of T2D is high and  increasing1.
The Tehran Lipid and Glucose Study (TLGS) is a long-term community-based lifestyle intervention program 
aimed at preventing non-communicable diseases and their risk  factors30. Previously, we showed that the life-
style intervention in the TLGS reduced T2D incidence and its risk factors including obesity, dyslipidemia, and 
dysglycemia short-term (after 3 years)17. The current study evaluates the long-term effectiveness of the TLGS 
intervention on the incidence of T2D and its risk factors.
Methods
Study design and participants. The TLGS was designed and implemented at two main junctures: (i) a 
cross-sectional study of the prevalence of NCDs and their risk factors implemented from 1999 to  200130 and (ii) 
a prospective follow-up study along with lifestyle interventions and triennial data recollection. The protocol of 
TLGS has been published  previously30. Briefly, three areas in District 13 of Tehran were selected for the study. 
One district was assigned to receive lifestyle intervention, and two other communities, far from the interven-
tion area, were allocated to the control group. Of the total population living in the three areas (total population: 
27,551: intervention area: 10,761, control areas: 7,858 + 8,932), 10,368 individuals who aged ≥ 20 years provided 
informed consent. Of these individuals, 1,164 had T2D at baseline and were excluded. As a result, 9,204 eligi-
ble participants were left for this study (5,739 participants in the control group and 3,465 participants in the 
intervention group). We used information of all eligible participants in the primary analysis of this study after 
imputing the missing values. In the sensitivity analysis, however, of the 9,204 eligible participants for this study, 
we excluded 2,158 participants who were absent at follow-up (23%), 178 participants with missing status for T2D 
in their follow-ups (2%), and 910 participants with missing values for confounders and blood glucose at baseline 
(10%). Eventually, the data of the remaining 5,958 participants (3,906 participants in the control group and 2052 
in the intervention group) were used in the sensitivity analysis.
Clinical and laboratory measurements. The details of clinical and laboratory measurements have been 
reported  previously30. Briefly, all participants were examined at the TLGS Clinic between February 1999 and 
August 2001 (wave 1) and were followed up through four times: wave 2: Oct 2001–Sep 2005; wave 3: Apr 2005–
Sep 2008; wave 4: Jul 2008–Oct 2011; and wave 5: Sep 2011–Jan 2015. In each wave, data on demographics, 
socioeconomic status, past medical history, physical activity, and smoking status were collected by completing 
a 110-item questionnaire. The Lipid Research Clinic (LRC) questionnaire in the baseline examination (wave 1) 
and the Modifiable Activity Questionnaire (MAQ) in waves 2–5 were used to assess the physical activity  level30.
Dietary intake was collected using a validated 168-item food frequency questionnaire (FFQ)31,32 in waves 
3–5. The FFQ was used to collect information on 17 food groups including whole grains, refined grains, dairy 
products, vegetables, fruits, legumes, meats, poultry, fish, nuts, seeds, dry beans, fat, oil, tea, coffee, salt, and 
simple  sugars31,32. In our previous studies, we showed that the FFQ was reliable and valid for assessing the intake 
of different food groups in the TLGS  population31,32. Furthermore, in another TLGS sub-study, dietary intake 
data of 578 randomly selected participants in the control group and the intervention group were collected at 
the baseline (wave 1) using the FFQ. The results showed that there was no difference between intervention and 
control  group33.
Anthropometric and blood pressure measurements were taken according to standard  protocols30. A blood 
sample was drawn after 12–14 h of overnight fasting to measure fasting plasma glucose (FPG), 2 h-postprandial 
plasma glucose (2 h-PG), high-density lipoprotein cholesterol (HDL-C), triglycerides, and total cholesterol. For 
the oral glucose tolerance test, 75 g anhydrous glucose was administered  orally30. All the measurements were 
taken in both the intervention and control groups.
Definition of terms. Current smoking was ascertained in participants who smoked cigarettes at least once 
a day or those who smoked cigarettes occasionally. Low physical activity was defined as having less than 3 days 
of performing sports or heavy physical activity per week in wave 1 of study (based on the LRC questionnaire) 
and as having less than 600 metabolic equivalents of task (MET) per week in waves 2–5 (based on MAQ ques-
tionnaire)30.
The quality of participants’ diets was assessed according to Dietary Approaches to Stop Hypertension (DASH) 
dietary  plan34. To this end, the cut-offs defined by the DASH diet concordance score (DASH score) was  used34.
We discarded measurements collected after contamination. Contamination occurred if a participant assigned 
to the intervention group moved out from the intervention community or a participant assigned to the control 
group moved into the intervention community in one of the follow-up waves. A total of 267, 357, and 108 par-
ticipants in the intervention group moved out from the intervention community in waves 3, 4, and 5, respectively. 
Also, 15, 11, and 11 participants in the control group moved into the intervention community in waves 3, 4, and 
5, respectively. The data collected after contamination were discarded and the data before the contamination 
were used as the last available follow-up.
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Outcomes. The primary outcome was the incidence of T2D. T2D was ascertained as FPG ≥ 7.0 mmol/L or 
2 h-PG ≥ 11.1 mmol/L and/or taking glucose-lowering  medication35. The event date was considered as the half-
time between the first date that T2D was diagnosed and the last known disease-free date.
Secondary outcomes were the difference between the study groups in physical activity, smoking status, energy 
intake, quality of diet, body mass index (BMI), waist circumference (WC), FPG, 2 h-PG, triglycerides, High-
Density Lipoproteins (HDL) cholesterol, and total cholesterol in the follow-up waves. The difference in change 
from baseline was also assessed for physical activity, smoking status, BMI, WC, FPG, 2 h-PG, triglycerides, HDL, 
and total cholesterol in the follow-up waves. The difference in change from baseline was not assessed for energy 
intake and quality of diet because these measurements were not collected at the baseline.
Description of lifestyle intervention. Details of the lifestyle intervention have been reported 
 previously17,30,36–38; briefly, the lifestyle intervention design was adapted from the North Karelia  project39,40 and 
using American Heart Association guidelines. For this purpose, findings of the need assessments and Knowl-
edge, Attitude, and Practice (KAP) studies in the TLGS communities were also  used41,42. The lifestyle interven-
tion was performed to prevent non-communicable diseases and improve risk factors of the subject through 
improving diet, increasing physical activity, and encouraging smoking cessation. The interventions had three 
components: family-based, school-based, and community-wide interventions. On the other hand, the control 
group received routine health care.
Family‑based lifestyle intervention. The families in the intervention area were invited to receive a single face-
to-face lifestyle intervention educational session between waves 1 and 2 of the study (between 1999 and 2001). 
The session was initiated with individual consultation and a 2-h educational class in small groups. The session 
included structured advice about lifestyle changes related to improving dietary patterns, increasing physical 
activity, and smoking cessation using slide and video presentations. All smokers were invited to take part in a 
motivational consult and then referred to a cessation clinic.
Residents from the intervention community received health newsletters named “Courier of Health” every 
three months (between 2001 and 2011). The newsletters contained information about health topics including 
the food pyramid guide, weight management, health hazards of smoking, smoking-cessation techniques, the 
importance of daily walking, and regular physical activity, and specific exercise recommendations. Moreover, 
they contained summarized findings of the TLGS, including the prevalence of risk factors in their community. 
Pamphlets and booklets on specific topics related to lifestyle management were also distributed 2–4 times per 
year among the residents of the intervention community. TLGS staff collected information on how many families 
read the pamphlets and booklets in each wave through telephone surveys. Telephone surveys showed that 50% 
of households had received and paid attention to the educational pamphlets and health  newsletters37.
Community‑wide intervention. Participants in the intervention area were also encouraged to participate in 
public education in 2–4 community gatherings annually for 1.5 to 3  h between 2001 and 2011. The gather-
ings included social events, seminars, and religious ceremonies, particularly at mosques in the holy month of 
Ramadan. Public events on occasions such as World Tobacco Day and World Diabetes Day were also held. Com-
munity health projects such as sports competitions, developing sports facilities in the community, providing 
subsidies for local gyms and pools, and health promotion advertisements (billboards) were also established in 
the intervention community between 2001 and 2011. More than 80% of the households participated in at least 
one of public gatherings for national or religious holidays between every two  examinations38.
School‑based intervention. A total of 12 schools across the intervention community implemented an ongoing 
school-based intervention that directly targeted students, parents, teachers, staff, and the school  environment36. 
Briefly, since 2001, a total of 12 healthy lifestyle sessions (45 min each) were held for the 1st-grade students, 
followed with three sessions for students of grades 2 and 3, in each school year. Sessions included educational 
courses for students including “living tobacco-free” classes. The intervention also included forming the school’s 
“health team” by students with the aim of peer  education38 and labelling snacks sold at the school’s shop regard-
ing their healthiness.
For parents, three educational sessions (60 min each) were conducted for each grade in addition to a group 
discussion each  year36. For teachers, 2-day seminars and 45-min class focusing on the knowledge and skills 
regarding healthy behaviours were held  annually36. Moreover, smoking was prohibited for all the schoolchildren, 
teachers, and employees inside the school.
Statistical analysis. Baseline characteristics were summarized using mean (± SD) values for continuous 
and frequencies (%) for categorical variables in the control and intervention groups. Since triglycerides had a 
skewed distribution, it was summarized by the median (interquartile range).
Cox proportional hazard models were fitted to compare the incidence rate of the T2D in the study groups 
accounting for baseline value of potential confounders (i.e., age, sex, area of residence, education level, family 
history of diabetes, smoking, low physical activity, WC, BMI, systolic blood pressure, diastolic blood pressure, 
FPG, 2 h-PG, total cholesterol, triglycerides, and HDL-C, and self-reported drug consumption for hypertension, 
and dyslipidemia) and clustered nature of data for families (i.e., using robust standard errors). Also, the effect 
of the intervention in each wave was estimated by restricting the Cox proportional hazard models to the data 
collected until that particular wave. For example, to estimate the effect of the intervention until the end of wave 
3, we only used the data collected from waves 1–3 and discarded the data collected in waves 4 and 5.
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To compare the risk factor levels between the study groups in different waves, generalized estimating equa-
tions (GEE) were fitted in a long-form dataset including data from waves 2–543. In each model, the level of risk 
factor was defined as the outcome and the predictors were defined to be baseline level of risk factor, time-point 
variable (i.e., waves 2–5), interventions status (control and intervention), an interaction term between interven-
tion status and time-point variable, and potential confounders (i.e., age, sex, area of residence, education level, 
family history of diabetes, smoking, low physical activity, WC, BMI, systolic blood pressure, diastolic blood 
pressure, FPG, 2 h-PG, total cholesterol, triglycerides, and HDL-C, and self-reported drug consumption for 
hypertension, and dyslipidemia). The model also accounted for the clustered nature of data due to repeated 
measures using an auto-regressive correlation matrix (the autoregressive process of order 1). An autoregressive 
correlation matrix was chosen since measurements taken further apart were less correlated than those taken 
closer  together44. Logit link function for binary outcomes and identity link function for continuous outcomes 
were used in the GEE models.
To compare the change from baseline for the risk factor levels between the study groups in different waves, 
GEE models with similar link functions (as described above) and autoregressive correlation matrix were fitted 
in a long-form dataset including data from waves 1–543. In each model, the level of risk factor was defined as the 
outcome and the predictors were defined to be time-point variable (i.e., waves 1–5), intervention status (con-
trol and intervention), the interaction term between intervention status and time-point variable, and potential 
confounders (as listed above). The estimated coefficient for interaction terms between intervention status and 
time-point variable were used to compare study groups in change in risk factor levels from baseline to different 
waves of  study43.
In the primary analysis for primary outcome (incidence of T2D), we imputed the baseline missing values 
of BMI (n = 230), WC (n = 269), family history of T2D (n = 394), low-physical activity (n = 163), education level 
(n = 10), smoking status (n = 158), systolic/diastolic blood pressure (n = 209), FPG (n = 299), 2 h-PG (n = 880), 
total cholesterol (n = 297), triglycerides (n = 300), HDL (n = 307)m T2D status at the end of follow-up (n = 2,270), 
and time-to-event (n = 2,305). Ice package in Stata was used to produce 10 imputed datasets using linear regres-
sion models for imputing continuous variables, logistic regression for binary variables, and ordinal regression 
models for ordinal  variables45–47. We imputed the time-to-event variable as described in ice package documen-
tations and previous  studies45–47. To analyze the secondary outcomes, we also imputed data of risk factors in 
follow-up waves (waves 2–5) using similar  methods45–47. For each analysis, estimates from imputed datasets 
were combined using Rubin’s  rule45–47. In the complete-case analysis, similar models were fitted in those with 
complete data (n = 5,958).
To account for multiple comparisons in the secondary aim of the study, the corrected p-value threshold was 
calculated and reported using the  Bonferroni48 formula. Estimates with p-values less than Bonferroni threshold 
were considered as statistically significant. Analyses were performed using the Stata statistical software (version 
14 SE).
Research ethics. The ethics committee of the Research Institute for Endocrine Sciences, Shahid Beheshti 
University of Medical Sciences confirmed the design of the TLGS study. Methods were carried out following the 
relevant guidelines and regulations. All participants provided written informed consent.
Results
Of 9,204 included participants, 5,285 ones were female (57.4%) with mean (± SD) age and BMI of 
41.1 ± 14.52 years and 26.5 ± 4.7 kg/m2, respectively (Table 1). As compared to participants in the intervention 
group, participants in the control group had significantly higher physical activity (25% vs. 22%), education, 
smoking prevalence (14% vs. 11%), and FPG (4.99 vs. 4.96 mmol/L) and lower WC (86.8 vs. 87.4 cm) at baseline 
(Table 1).
After a median follow-up of 3.5 years (IQR 2.7–4.2) (wave 2), 4.5% (95% CI 3.7%; 5.2%) of participants in the 
control group and 3.8% (95% CI 3.1%; 4.5%) participants in the intervention group developed T2D. It resulted 
in incidence rates of 14.4 and 9.2 per 1,000 person-years in the control and the intervention groups, respectively. 
The hazard of incident T2D was significantly 30% lower in the intervention group compared to the control group 
(IRR 0.70 [0.53; 0.91], p-value: 0.009). This difference, however, disappeared in the following waves (Table 2). 
After a median follow-up of 11.9 years (IQR 6.6–13.3) (wave 5), 14.1% (95% CI 13.2%; 15.1%) of participants in 
the control group and 11.1% (95% CI 10.1%; 12.6%) of participants in the intervention group were diagnosed 
with T2D with an incidence rate of 12.9 and 11.9 per 1,000 person-years in the control and intervention groups, 
respectively. There was a non-significant 6% reduction in the incidence rate of T2D in the intervention group 
compared to the control group [Hazard ratio: 0.94 (0.81, 1.08)]. Findings from complete case analyses were 
similar to those from the primary analysis (Table 2).
Table 3 compares the change in the lifestyle risk factors of T2D. Based on the Bonferroni method, the cor-
rected p-value threshold was 0.00058 for the secondary aim of the study. Adjusting for the differences between 
study groups at baseline, at wave 2 of TLGS, the intervention group indicates a significantly lower FPG (by 
0.1 mmol/L; p-value < 0.0001) and a significantly higher HDL (by 0.03 mmol/L; p-value < 0.0001). Similar find-
ings were observed when comparing the changes from baseline to wave 2 for each risk factor. In the final wave 
(wave 5), the intervention group had significantly higher levels of DASH score (0.2; p-value < 0.0001). Generally, 
similar results were observed in complete case analysis (data not shown).
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Discussion
This research is one of the few studies reporting the long-term effects of a community-wide lifestyle intervention 
on T2D prevention in an LMIC. Although the intervention reduced the risk of T2D by 30% short-term (wave 2: 
3.5 years of follow-up), this effect was not maintained until the end of the study (wave 5) with a non-significant 
6% reduction in the risk of T2D after 11.9 years of follow-up. Nevertheless, the effect of lifestyle intervention on 
the improvement of diet quality maintained after 11.9 years.
Our findings are in line with those of a recent study in the TLGS that showed that lifestyle intervention pre-
vented metabolic syndrome short-term (waves 2 and 3). However, this effect was not maintained in the long run 
(wave 4 and wave 5)37. Moreover, our recent study in the adolescent participants of the TLGS, showed that the 
lifestyle intervention prevented metabolic syndrome in a short time (wave 2) but not in long-term (wave 4)36. 
There is limited evidence about the long-term effects of a community-wide lifestyle intervention program on the 
incidence of T2D or the prevalence of its risk factors. Repeated surveys in the Isfahan Healthy Heart Program, 
a multi-component community-wide lifestyle intervention, showed a non-significant (0.8%) reduction in the 
prevalence of T2D in the intervention group compared to the controls after 7 years of follow-up29. Similarly, 
studies conducted in high-income countries showed no significant reduction in the incidence of T2D in the 
long-term14,49,50. Regarding changes in the risk factors of T2D, several studies showed that the community-wide 
lifestyle intervention programs had significant long-term effects on the reduction of T2D risk  factors6–8,51. In a 
community-wide lifestyle intervention in the Coalfields district of New South Wales,  Australia52, a significant 
reduction in poor dietary habits and BMI was observed after 10 years of follow-up.
Our research demonstrates that a low-cost and pragmatic intervention consisting of a face-to-face educa-
tional session embedded in a community-wide intervention can reduce the incidence of T2D short-term and 
improve the quality of diet in the long-term. Therefore, if scaled up, this program can prevent a considerable 
Table 1.  Comparison between baseline characteristics by study group; Tehran Lipid and Glucose Study 1999–
2015. Baseline characteristics were summarized using mean (standard deviation: SD) values for continuous 
and frequencies (%) for categorical variables. Since triglycerides had a skewed distribution, it was summarized 
by the median (interquartile range). Baseline characteristics were compared between study groups using 
student’s T-test, chi-square test, and Mann–Whitney U test, whichever appropriate.
Characteristics Level Control (n = 5,739) Intervention (n = 3,465) p-value
Age (year) 40.85 (14.30) (n = 5,739) 41.43 (14.88) (n = 3,465) 0.060
Sex (%)
Male 2,463 (42.9%) 1,456 (42.0%) 0.40
Female 3,276 (57.1%) 2,009 (58.0%)
Missing 0 (0.0%) 0 (0.0%)
Family history of type 2 diabetes
No 4,057 (70.7%) 2,448 (70.6%) 0.57
Yes 1,422 (24.8%) 883 (25.5%)
Missing 260 (4.5%) 134 (3.9%)
Education (%)
Less than 6 years 1,757 (30.6%) 1,212 (35.0%)  < 0.001
6–12 years 3,198 (55.7%) 1,837 (53.0%)
Post-school education 776 (13.5%) 414 (11.9%)
Missing 8 (0.1%) 2 (0.1%)
Low physically active (%)
No 1,438 (25.1%) 769 (22.2%) 0.001
Yes 4,188 (73.0%) 2,646 (76.4%)
Missing 113 (2.0%) 50 (1.4%)
Current smoking (%)
No 4,802 (83.7%) 2,979 (86.0%) 0.013
Yes 827 (14.4%) 438 (12.6%)
Missing 110 (1.9%) 48 (1.4%)
Weight (kg) 70.03 (13.06) (n = 5,584) 69.79 (13.08) (n = 3,390) 0.39
Height (cm) 162.74 (9.21) (n = 5,600) 162.05 (9.06) (n = 3,408)  < 0.001
Body mass index (kg/m2) 26.48 (4.71) (n = 5,584) 26.59 (4.69) (n = 3,390) 0.28
Waist circumference (cm) 86.81 (12.11) (n = 5,564) 87.36 (12.10) (n = 3,371) 0.036
Systolic blood pressure (mm Hg) 117.75 (17.61) (n = 5,593) 118.25 (18.31) (n = 3,402) 0.20
Diastolic blood pressure (mm Hg) 77.30 (10.47) (n = 5,593) 77.14 (10.82) (n = 3,402) 0.47
Fasting plasma glucose (mmol/L) 4.99 (0.54) (n = 5,554) 4.96 (0.55) (n = 3,351) 0.024
Postprandial plasma glucose (mmol/L) 5.92 (1.65) (n = 5,194) 5.93 (1.63) (n = 3,130) 0.77
Total cholesterol (mmol/L) 5.32 (1.18) (n = 5,555) 5.33 (1.15) (n = 3,352) 0.62
HDL-C (mmol/L) 1.10 (0.28) (n = 5,550) 1.09 (0.28) (n = 3,347) 0.68
Triglycerides (mmol/L) 1.54 (1.05, 2.24) (n = 5,554) 1.54 (1.03, 2.26) (n = 3,350) 0.67
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number of new cases of T2D as well as other non-communicable diseases in Iran. However, we also showed 
that the intervention was not effective in the long term. Underscoring this issue needs more attention to ensure 
lifestyle intervention effectiveness in the long-term. There is limited evidence regarding the factors contributing 
to the maintenance of long-term success of community-wide lifestyle intervention programs especially beyond 
a period of 24 months53. Previous studies suggested that the lack of maintenance in the effects of lifestyle inter-
ventions may be due to the inability of participants in maintaining healthy eating and exercise behaviours over 
 time53,54 and long-term maintenance may increase by removing the barriers in lifestyle  modification55. Based on 
previous  studies56–61, the most important barriers to healthy nutrition and physical activity were interpersonal/
cultural effects, lack of access to healthy foods, food preferences, media advertisements, nutrition transition, 
lack of time, motivation, and prioritizing other activities over sports and high costs of the facilities. Moreover, 
a booster face-to-face educational session every 3 years might help maintain the effectiveness of the lifestyle 
intervention for a longer period.
This study has several strengths including a large sample size and more than a decade-long follow-up. Moreo-
ver, the team and the methods for data collection had minimal changes throughout the study. This is one of 
the few community trials that has collected and compared the dietary patterns in detail between study groups. 
The findings of this study, however, should be interpreted in light of several limitations of which, such as the 
non-randomized design of the study. As another limitation, 35% of participants had at least one missing value 
in their variables of interest. Moreover, TLGS did not collect data on T2D knowledge. An increase in T2D 
knowledge is one of the main goals of community-wide lifestyle intervention programs for T2D prevention as 
it can result in the gradual development of healthy beliefs/attitudes and a meaningful change in behaviour. Lack 
of T2D knowledge data averted further investigations on potential causes for lack of long-term effectiveness. 
For example, T2D knowledge data could have helped distinguish whether the lack of long-term effectiveness is 
mainly due to external and internal barriers that prevent participants to apply their knowledge in practice or it 
was mainly due to a decrease in T2D knowledge of TLGS participants.
In conclusion, the lifestyle intervention reduced the risk of T2D by 30% after 3.5 years of follow-up (wave 2 
of study), a change that was not maintained in the following waves with a non-significant 6% reduction in T2D 
risk after 11.9 years of follow-up. Nevertheless, the effect of lifestyle intervention on the quality of diet maintained 
even after 11.9 years of follow-up.
Table 2.  The incidence rate of T2D by study group; the Tehran Lipid and Glucose Study 1999–2015. In the 
primary analysis, we imputed the baseline missing values of BMI (n = 230), WC (n = 269), family history of 
type 2 diabetes (n = 394), low-physical activity (n = 163), education level (n = 10), smoking status (n = 158), 
systolic/diastolic blood pressure (n = 209), FPG (n = 299), 2 h-PG (n = 880), total cholesterol (n = 297), 
triglycerides (n = 300), HDL (n = 307), all-wave follow-up time (n = 2,305), and T2D status (n = 2,270). Ice 
package in Stata was used to produce 10 imputed datasets using linear regression models for imputing 
continuous variables, logistic regression for binary variables, and ordinal regression models for ordinal 
variables. We imputed the time-to-event variable as described in ice package documentations and previous 
studies. Moreover, we used age, sex, drug consumption for dyslipidemia, and hypertension as axillary variables 
in the imputation process. In the complete-case analysis, similar models were fitted in those with complete data 
(n = 5,958). Cox proportional hazard models were fitted to compare the incidence rate of the T2D in the study 
groups accounting for baseline value of potential confounders (i.e., age, sex, area of residence, education level, 
family history of diabetes, smoking, low physical activity, WC, BMI, systolic blood pressure, diastolic blood 
pressure, FPG, 2 h-PG, total cholesterol, triglycerides, and HDL-C, and self-reported drug consumption for 
hypertension, and dyslipidemia) and clustered nature of data for families (i.e., using robust standard errors). 
Moreover, the effect of the intervention in each wave was estimated by restricting the Cox proportional hazard 
models to the data collected until that particular wave (e.g., to estimate the effect of the intervention until the 
end of wave 3), we only used the data collected from waves 1–3 and discarded the data collected in waves 4 and 
5.
Primary analysis
Follow-up (years), median (IQR) Hazard ratio (95% CI) p-value
Wave 2 3.5 [2.7; 4.2] 0.70 [0.53; 0.91] 0.009
Wave 3 6.0 [5.2; 7.1] 0.96 [0.79; 1.18] 0.718
Wave 4 9.0 [6.8; 10.2] 0.94 [0.80; 1.11] 0.468
Wave 5 11.9 [6.6; 13.3] 0.94 [0.81; 1.08] 0.385
Complete case analysis
Follow-up (years), median (IQR) Hazard ratio (95% CI) p-value
Wave 2 3.4 [2.7; 4.2] 0.70 [0.51; 0.97] 0.034
Wave 3 6.0 [5.3; 7.1] 0.97 [0.77; 1.24] 0.830
Wave 4 9.1 [7.1; 10.2] 0.95 [0.79; 1.16] 0.641
Wave 5 12.0 [7.8; 13.3] 0.94 [0.80; 1.12] 0.505
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Risk factor
Wave 2 Wave 3 Wave 4 Wave 5
Mean (SD)
Change from 
baseline Mean (SD)
Change from 
baseline Mean (SD)
Change from 
baseline Mean (SD)
Change from 
baseline
Waist
Intervention 91.5 (12.0) 4.2 (3.9, 4.5) 92.7 (12.4) 5.4 (5.1, 5.8) 96.2 (11.8) 8.9 (8.6, 9.3) 96.1 (11.8) 8.8 (8.4, 9.3)
Control 91.6 (12.1) 4.9 (4.6, 5.1) 92.3 (12.3) 5.6 (5.4, 5.8) 96.2 (11.8) 9.4 (9.2, 9.7) 96.3 (11.8) 9.5 (9.2, 9.8)
Between group 
difference
− 0.5 (− 0.8, − 0.1)
p-value = 0.021
− 0.6 (− 1.0, 
− 0.3)
p-value < 0.0001
0.0 (− 0.3, 0.4)
p-value = 0.875
− 0.2 (− 0.6, 0.2)
p-value = 0.434
− 0.3 (− 0.7, 0.0)
p-value = 0.065
− 0.5 (− 0.9, − 0.1)
p-value = 0.017
− 0.5 (− 0.9, − 0.1)
p-value = 0.011
− 0.7 (− 1.1, − 0.2)
p-value = 0.004
Body mass index
Intervention 27.6 (4.8) 1.0 (0.8, 1.2) 28.0 (4.8) 1.4 (1.2, 1.6) 28.5 (6.7) 1.9 (1.7, 2.2) 28.7 (5.1) 2.1 (1.9, 2.4)
Control 27.5 (4.8) 1.0 (0.9, 1.2) 27.9 (4.8) 1.4 (1.3, 1.6) 28.6 (9.9) 2.1 (2.0, 2.3) 28.8 (5.3) 2.3 (2.1, 2.5)
Between group 
difference
0.0 (− 0.2, 0.2)
p-value = 0.957
0.0 (− 0.2, 0.2)
p-value = 0.821
− 0.1 (− 0.3, 0.1)
p-value = 0.504
− 0.1 (− 0.3, 0.2)
p-value = 0.509
− 0.2 (− 0.5, 0.1)
p-value = 0.219
− 0.2 (− 0.5, 0.1)
p-value = 0.251
− 0.1 (− 0.3, 0.1)
p-value = 0.190
− 0.2 (− 0.4, 0.1)
p-value = 0.273
Fasting plasma glucose
Intervention 4.99 (0.76) 0.03 (− 0.01, 0.06) 5.13 (0.97) 0.17 (0.13, 0.21) 5.49 (1.14) 0.53 (0.48, 0.57) 5.60 (1.38) 0.64 (0.59, 0.69)
Control 5.13 (0.72) 0.14 (0.11, 0.17) 5.09 (0.88) 0.11 (0.07, 0.14) 5.47 (1.20) 0.49 (0.45, 0.52) 5.60 (1.44) 0.61 (0.57, 0.65)
Between group 
difference
− 0.13 (− 0.17, 
− 0.08)
p-value < 0.0001
− 0.11 (− 0.16, 
− 0.07)
p-value < 0.0001
0.05 (0.00, 0.09)
p-value = 0.035
0.06 (0.01, 0.11)
p-value = 0.019
0.03 (− 0.02, 0.08)
p-value = 0.211
0.04 (− 0.01, 0.10)
p-value = 0.133
0.02 (− 0.04, 0.08)
p-value = 0.539
0.03 (− 0.04, 0.10)
p-value = 0.358
Post-prandial glucose
Intervention 6.1 (2.2) 0.2 (0.1, 0.3) 6.2 (2.6) 0.3 (0.2, 0.4) 6.7 (3.0) 0.8 (0.7, 0.9) 7.2 (3.6) 1.3 (1.2, 1.4)
Control 6.3 (2.2) 0.4 (0.3, 0.4) 6.2 (2.5) 0.3 (0.2, 0.4) 6.6 (3.0) 0.8 (0.7, 0.8) 7.2 (3.6) 1.4 (1.2, 1.5)
Between group 
difference
− 0.1 (− 0.3, 0.0)
p-value = 0.021
− 0.1 (− 0.3, 0.0)
p-value = 0.009
0.0 (− 0.1, 0.1)
p-value = 0.800
0.0 (− 0.1, 0.1)
p-value = 0.751
0.0 (− 0.1, 0.2)
p-value = 0.720
0.0 (− 0.1, 0.2)
p-value = 0.815
− 0.1 (− 0.2, 0.1)
p-value = 0.496
− 0.1 (− 0.2, 0.1)
p-value = 0.513
Triglycerides
Intervention 1.74 (1.10) − 0.09 (− 0.12, − 0.05) 1.73 (1.08)
− 0.10 (− 0.14, 
− 0.06) 1.68 (1.05)
− 0.15 (− 0.20, 
− 0.11) 1.71 (1.01)
− 0.11 (− 0.16, 
− 0.07)
Control 1.80 (1.20) − 0.02 (− 0.05, 0.01) 1.78 (1.09)
− 0.04 (− 0.08, 
− 0.01) 1.73 (1.12)
− 0.10 (− 0.13, 
− 0.06) 1.73 (1.01)
− 0.10 (− 0.14, 
− 0.06)
Between group 
difference
− 0.06 (− 0.11, 
− 0.01)
p-value = 0.012
− 0.07 (− 0.11, 
− 0.02)
p-value = 0.007
− 0.05 (− 0.09, 
− 0.01)
p-value = 0.021
− 0.06 (− 0.11, 
0.00)
p-value = 0.037
− 0.05 (− 0.09, 
− 0.01)
p-value = 0.025
− 0.05 (− 0.11, 
0.00)
p-value = 0.061
− 0.01 (− 0.05, 
0.03)
p-value = 0.629
− 0.02 (− 0.07, 
0.04)
p-value = 0.581
HDL-cholesterol
Intervention 1.02 (0.27) − 0.08 (− 0.09, − 0.07) 1.11 (0.27) 0.02 (0.01, 0.03) 1.22 (0.29) 0.13 (0.11, 0.14) 1.28 (0.32) 0.19 (0.18, 0.20)
Control 0.99 (0.26) − 0.10 (− 0.11, − 0.10) 1.07 (0.27)
− 0.03 (− 0.04, 
− 0.02) 1.23 (0.29) 0.13 (0.12, 0.14) 1.26 (0.32) 0.17 (0.16, 0.18)
Between group 
difference
0.03 (0.01, 0.04)
p-value < 0.0001
0.03 (0.02, 0.04)
p-value < 0.0001
0.04 (0.03, 0.06)
p-value < 0.0001
0.05 (0.03, 0.06)
p-value < 0.0001
− 0.01 (− 0.02, 
0.00)
p-value = 0.173
− 0.01 (− 0.03, 
0.01)
p-value = 0.375
0.02 (0.01, 0.03)
p-value = 0.001
0.02 (0.00, 0.03)
p-value = 0.013
Total cholesterol
Intervention 4.9 (1.0) − 0.4 (− 0.4, − 0.3) 5.0 (1.0) − 0.3 (− 0.3, − 0.3) 5.0 (1.0) − 0.3 (− 0.4, − 0.3) 5.1 (1.0) − 0.2 (− 0.2, − 0.1)
Control 5.0 (1.1) − 0.3 (− 0.3, − 0.3) 5.0 (1.0) − 0.3 (− 0.4, − 0.3) 5.1 (1.0) − 0.2 (− 0.3, − 0.2) 5.1 (1.0) − 0.2 (− 0.2, − 0.2)
Between group 
difference
− 0.1 (− 0.1, 0.0)
p-value = 0.012
− 0.1 (− 0.1, 0.0)
p-value = 0.010
0.0 (0.0, 0.1)
p-value = 0.053
0.0 (0.0, 0.1)
p-value = 0.170
− 0.1 (− 0.1, 0.0)
p-value = 0.004
− 0.1 (− 0.1, 0.0)
p-value = 0.015
0.0 (0.0, 0.1)
p-value = 0.238
0.0 (0.0, 0.1)
p-value = 0.499
DASH score
Intervention NA NA 5.9 (1.5) NA 6.8 (1.4) NA 6.9 (1.4) NA
Control NA NA 5.8 (1.5) NA 6.6 (1.5) NA 6.7 (1.5) NA
Between group 
difference NA NA
0.1 (0.0, 0.3)
p-value = 0.091 NA
0.2 (0.1, 0.3)
p-value = 0.0001 NA
0.2 (0.1, 0.3)
p-value = 0.0003 NA
Energy intake
Intervention NA NA 2,347 (1,041) NA 2,481 (1,025) NA 2,432 (1,020) NA
Control NA NA 2,371 (1,066) NA 2,490 (1,053) NA 2,366 (1,007) NA
Between group 
difference NA NA
− 17 (− 106, 72)
p-value = 0.690 NA
− 2 (− 72, 68)
p-value = 0.946 NA
73 (16, 131)
p-value = 0.014 NA
N (%)
Change from 
baseline (Odds 
ratio)
N (%)
Change from 
baseline (Odds 
ratio)
N (%)
Change from 
baseline (Odds 
ratio)
N (%)
Change from 
baseline (Odds 
ratio)
Smoking
Intervention 424 (12.2) 0.9 (0.8, 1.1) 376 (10.9) 0.8 (0.7, 0.9) 379 (10.9) 0.8 (0.7, 1.0) 384 (11.1) 0.8 (0.7, 1.0)
Control 878 (15.3) 1.1 (1.0, 1.1) 832 (14.5) 1.0 (0.9, 1.1) 783 (13.6) 0.9 (0.8, 1.0) 768 (13.4) 0.9 (0.8, 1.0)
Between group 
difference
0.72 (0.56, 0.91)
p-value = 0.008
0.88 (0.76, 1.02)
p-value = 0.085
0.62 (0.48, 0.79)
p-value < 0.001
0.81 (0.69, 0.96)
p-value = 0.014
0.74 (0.57, 0.96)
p-value = 0.024
0.89 (0.74, 1.08)
p-value = 0.246
0.79 (0.61, 1.04)
p-value = 0.092
0.93 (0.76, 1.14)
p-value = 0.496
Continued
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